← Leaderboards
Igor Matushansky
Columbia University Health Sciences
$789,380
Attributed
$789,380
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $169.9K · FY2006–12$200K$150K$100K$50K$0
'06
'07
'08
'09
'10
'11
'12
Funding mix
By agency
NIH$789,380 · 2
By mechanism
K08$679,536 · 1
F32$109,844 · 1
Top collaborators
No co-investigators on record.
Most similar at Columbia University Health Sciences
Same institution · by research overlap
- Mary Beth Terry$27,685,500
- Anil K Rustgi$51,275,906
- Alfred I Neugut$17,537,198
- Gary K Schwartz$24,362,901
- Andrew B Lassman$5,644,772
Others in their field
Top investigators on “Tumorigenesis”
- Scott W Lowe · Sloan-Kettering Inst Can Research$31,953,893
- Andrea Califano · Columbia University Health Sciences$29,337,086
- Pier Paolo Pandolfi · Sloan-Kettering Institute For Cancer Res$29,078,016
- Piotr Sicinski · Dana-Farber Cancer Inst$23,348,940
- Dario C. Altieri · Wistar Institute$22,047,659
- Eric C Holland · Sloan-Kettering Institute For Cancer Res$21,298,636
Research focus
TumorigenesisMaintenanceSarcomaTumorigenicPhenotypeLeadOncogenesPromotor (Genetics)TumorUndifferentiatedSignal TransductionEventCellsCell LineCareerAreaCancer ModelBaseFounder GenerationFutureDependenceDefectDesignBone Marrow
Grant awards (6)
The role of DKK1, a Wnt-Inhibitor, in Mesenchymal Differentiation/Sarcomagenesis$169,884
K08 · FY2012 · CA · contact PI
The role of DKK1, a Wnt-Inhibitor, in Mesenchymal Differentiation/Sarcomagenesis$169,884
K08 · FY2011 · CA · contact PI
The role of DKK1, a Wnt-Inhibitor, in Mesenchymal Differentiation/Sarcomagenesis$169,884
K08 · FY2010 · CA · contact PI
The role of DKK1, a Wnt-Inhibitor, in Mesenchymal Differentiation/Sarcomagenesis$169,884
K08 · FY2009 · CA · contact PI
Beta-catenin as a tumor suppressor in sarcomagenesis.$55,852
F32 · FY2008 · CA · contact PI
Beta-catenin as a tumor suppressor in sarcomagenesis.$53,992
F32 · FY2006 · CA · contact PI